[1] VALENCIA W M, FLOREZ H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control[J].BMJ,2017, 356:j1018. [2] KOPEL J, PENA-HERNANDEZ C, NUGENT K. Evolving spectrum of diabetic nephropathy[J].World J Diabetes,2019, 10(5):269-279. [3] MACGINLEY R, CHAMPION DE CRESPIGNY P J, GUTMAN T, et al. KHA-CARI guideline recommendations for renal biopsy [J].Nephrology(Carlton),2019, 24(12):1205-1213. [4] 张炯,刘志红. 多参数磁共振影像在评估肾脏纤维化中的应用[J].肾脏病与透析肾移植杂志, 2018, 27 (6):555-559. [5] PRUIJM M, MILANI B, BURNIER M. Blood oxygenation level-dependent MRI to assess renal oxygenation in renal diseases:progresses and challenges[J].Front Physiol,2017, 7:667. [6] SCHIFFER T A, FRIEDERICH-PERSSON M. Mitochondrial reactive oxygen species and kidney hypoxia in the development of diabetic nephropathy [J].Front Physiol,2017, 8:211. [7] FENG Y Z, YE Y J, CHENG Z Y, et al. Non-invasive assessment of early stage diabetic nephropathy by DTI and BOLD MRI [J].Br J Radiol,2020, 93(1105):20190562. [8] LI Z C, CAI Y Z, TANG Z G, et al. Lipo-prostaglandin E1 improves renal hypoxia evaluated by BOLD-MRI in patients with diabetic kidney disease [J].Clin Imaging,2018, 50:239-242. [9] ZHENG S S, HE Y M, LU J. Noninvasive evaluation of diabetic patients with high fasting blood glucose using DWI and BOLD MRI [J].Abdom Radiol,2021, 46(4):1659-1669. [10] DENG Y, YANG B, PENG Y, et al. Use of intravoxel incoherent motion diffusion-weighted imaging to detect early changes in diabetic kidneys [J].Abdom Radiol,2018, 43(10):2728-2733. [11] FENG Y Z, CHEN X Q, CHENG Z Y, et al. Non-invasive investigation of early kidney damage in streptozotocin-induced diabetic rats by intravoxel incoherent motion diffusion-weighted (IVIM) MRI [J].BMC Nephrol,2021, 22(1):321. [12] YE X J, CUI S H, SONG J W, et al. Using magnetic resonance diffusion tensor imaging to evaluate renal function changes in diabetic patients with early-stage chronic kidney disease [J].Clin Radiol,2019, 74(2):116-122. [13] MRDANIN T, NIKOLIĆ O, MOLNAR U, et al. Diffusion-weighted imaging in the assessment of renal function in patients with diabetes mellitus type 2 [J].MAGMA,2021, 34(2):273-283. [14] KAIMORI J Y, ISAKA Y, HATANAKA M, et al. Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence [J].Sci Rep,2017, 7(1):5731. [15] 魏伟,贺太平,樊梨花,等. 扩散峰度成像在早期糖尿病肾病中的应用研究 [J].实用放射学杂志, 2018, 34 (11):1728-1730. [16] MORA-GUTIÉRREZ J M, GARCIA-FERNANDEZ N, SLON ROBLERO M F, et al. Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy [J].J Magn Reson Imaging,2017, 46(6):1810-1817. [17] RITT M, JANKA R, SCHNEIDER M P, et al. Measurement of kidney perfusion by magnetic resonance imaging:comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome[J].Nephrol Dial Transplant,2010, 25(4):1126-1133. [18] WANG J, ZHANG Y, YANG X, et al. Hemodynamic effects of furosemide on renal perfusion as evaluated by ASL-MRI [J].Acad Radiol,2012, 19(10):1194-1200. [19] ZHANG X, ZHU X, FERGUSON C M, et al. Magnetic resonance elastography can monitor changes in medullary stiffness in response to treatment in the swine ischemic kidney [J].MAGMA,2018, 31(3):375-382. [20] KIRPALANI A, HASHIM E, LEUNG G, et al. Magnetic resonance elastography to assess fibrosis in kidney allografts [J].Clin J Am Soc Nephrol,2017, 12(10):1671-1679. [21] TEWES S, GUELER F, CHEN R, et al. Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains [J].PLoS One,2017, 12(3):e0173248. [22] WU J, SHI Z, ZHANG Y, et al. Native T1 mapping in assessing kidney fibrosis for patients with chronic glomerulonephritis [J].Front Med,2021, 8:772326.
2023, Vol. 40 
